The obesity medicine director calls prior authorization and step therapy red tape that can stop patients from ever starting a GLP-1, and explains what helps.
Recap by typeshit. Full story at The American Journal of Managed Care.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
19:56
A performance coach shares his own checklist for people beginning retatrutide, the Lilly drug that is still in trials and not approved.
He says this has gone on for around two years, meaning many people are taking a drug at scale before it has even reached the market.
Loading…